biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > A Discussion About Timelines

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Feb 24, 2022 10:17pm

155 Views

Post# 34460363

RE:RE:A Discussion About Timelines

Bwah hahaha!

beenthere says he doesn't read my posts. Has anybody else noticed that beenthere has never read anything other than the calendar?

beenthere, you're in search of the perfect insult. That's all you do on Stockhouse. In fact, you don't read anything about Bioasis, its science or commercial opportunities.

You didn't need to confess that you don't read anything. We all know that.

jd

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports